Literature DB >> 2545502

Hypomethylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis.

N Aiba1, S Nambu, K Inoue, H Sasaki.   

Abstract

In order to investigate how chronic liver diseases, including liver cirrhosis and chronic hepatitis, are associate with hepatocarcinogenesis in terms of gene alteration, the methylation states of the c-myc and c-Ki-ras genes were examined in 34 liver tissues from patients with chronic liver disease without hepatocellular carcinoma (HCC), 34 non-tumor liver tissues from patients with HCC, 18 HCC tissues and 31 control liver tissues. The methylation states were analyzed by the Southern hybridization method using the restriction endonuclease isoschizomers MspI and HpaII. The CCGG sites at the second exon of the c-myc gene tended to be more extensively hypomethylated both in chronic liver disease and in non-tumor tissues than in control livers. Whereas the CCGG sites of the c-Ki-ras, and the third exon of the c-myc gene tended to be hypomethylated only in HCC tissues in comparison with other tissue groups. These results suggest that chronic liver disease may be situated between normal liver and HCC based on the state of DNA methylation and associated with the development of HCC through hypomethylation of the c-myc and/or c-Ki-ras gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545502     DOI: 10.1007/BF02774324

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  29 in total

1.  Oncogenes in human primary hepatic cancer.

Authors:  J R Gu; L F Hu; Y C Cheng; D F Wan
Journal:  J Cell Physiol Suppl       Date:  1986

2.  DNA hypomethylation in ethionine-induced rat preneoplastic hepatocyte nodules.

Authors:  D Kanduc; A Ghoshal; E Quagliariello; E Farber
Journal:  Biochem Biophys Res Commun       Date:  1988-01-29       Impact factor: 3.575

Review 3.  DNA methylation patterns. Formation and function.

Authors:  A Razin; M Szyf
Journal:  Biochim Biophys Acta       Date:  1984-09-10

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  MspI, an isoschizomer of hpaII which cleaves both unmethylated and methylated hpaII sites.

Authors:  C Waalwijk; R A Flavell
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

6.  The expression of oncogenes in human developing liver and hepatomas.

Authors:  X K Zhang; D P Huang; D K Chiu; J F Chiu
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

7.  Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver.

Authors:  Y Kaneko; M Shibuya; T Nakayama; N Hayashida; G Toda; Y Endo; H Oka; T Oda
Journal:  Jpn J Cancer Res       Date:  1985-12

8.  Expression of oncogenes in human liver disease.

Authors:  Y Himeno; Y Fukuda; M Hatanaka; H Imura
Journal:  Liver       Date:  1988-08

9.  Expression of c-myc gene in human hepatoma.

Authors:  T S Su; L H Lin; W Y Lui; C M Chang; C K Chou; L P Ting; C P Hu; S H Han; F K P'eng
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

10.  Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.

Authors:  K Nishikura; A ar-Rushdi; J Erikson; R Watt; G Rovera; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  5 in total

1.  Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.

Authors:  N Wong; W C Lam; P B Lai; E Pang; W Y Lau; P J Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 2.  c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.

Authors:  Kang Zheng; Francisco Javier Cubero; Yulia A Nevzorova
Journal:  Genes (Basel)       Date:  2017-04-19       Impact factor: 4.096

3.  EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.

Authors:  Shengwei Zhang; Yonggang Pei; Fengchao Lang; Kunfeng Sun; Rajnish Kumar Singh; Zachary L Lamplugh; Abhik Saha; Erle S Robertson
Journal:  PLoS Pathog       Date:  2019-01-07       Impact factor: 6.823

4.  S-adenosyl-methionine (SAM) alters the transcriptome and methylome and specifically blocks growth and invasiveness of liver cancer cells.

Authors:  Yan Wang; ZhongSheng Sun; Moshe Szyf
Journal:  Oncotarget       Date:  2017-12-05

5.  MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.

Authors:  Hui Lin; Zhi-Ping Huang; Jiao Liu; Yun Qiu; Yuan-Ping Tao; Meng-Chao Wang; Hui Yao; Ke-Zhu Hou; Fang-Ming Gu; Xuan-Fu Xu
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.